Posted: September 29th, 2023
Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH, UPC, Court of First Instance – Munich (DE) Central Division, Judge-rapporteur Kupecz, 20 September 2023, Case no. UPC_CFI_1/2023 Rule 262.1(b) RoP requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence upon a request by a member of the public. To be informed of the […]
READ MOREPosted: September 29th, 2023
Astellas Institute for Regenerative Medicine v. Healios K.K, Riken, Osaka University, UPC, Court of First Instance – Munich (DE) Central Division, Judge-rapporteur Kupecz, 21 September 2023, Case no. UPC_CFI_75/2023 Rule 262.1(b) RoP requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence upon a request by a member of the public. […]
READ MOREPosted: September 21st, 2023
US biotech company 10x Genomics has been granted a preliminary injunction that prevents a competitor NanoString Technologies from selling products in 17 EU countries in a landmark ruling by the local division of the Unified Patent Court (UPC) in Munich. Dr Julia Traumann and Emmanuel Gougé of Pinsent Masons said the ruling, where 10x Genomics […]
READ MOREPosted: September 4th, 2023
Communication from the UPC: Upcoming hearing at the UPC Local Division Vienna Name of the parties: CUP&CINO Kaffeesystem-Vertrieb GmbH & Co. KG vs. Alpina Coffee Systems GmbH File number: ACT_528738/2023 Type of action: Application for provisional measures Language of proceedings: German Date: 13.9.2023 Time: 9:00 a.m. Location: Room 25, 3rd floor, Althanstraße 39-45, 1090 Vienna […]
READ MOREPosted: August 31st, 2023
The EPO announces the online conference ‘Litigation Matters 2023’ to be held online on 5-6 December 2023 The conference is organised in close co-operation with EPLAW, and features various prominent speakers, amongst which UPC Judge Rian Kalden, Presiding judge of the second panel of the Court of Appeal, former EPLAW Presidents Willem Hoyng and Klaus […]
READ MOREPosted: August 28th, 2023
Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH et al., Panel 1 of the Central Division (Section Munich), Order of the Judge-rapporteur András Kupecz, Case no. UPC_CFI_1/2023 Patent at issue: EP3666797 Amgen, Inc “Conclusion “4.53 Based on the above, it is concluded that at the point in time the Claimants brought their revocation action by lodging the […]
READ MOREPosted: August 24th, 2023
Communication from the UPC: Upcoming hearings at the Local Division Munich Upcoming hearings of the UPC Local Division Munich and instructions for the press on seat reservation Public hearing 1 Name of the parties: 10x Genomics and others v. NanoString Technologies and others File number: ACT_459746/2023 UPC_CFI_2/2023 Type of action: application for provisional measures Language […]
READ MOREPosted: August 10th, 2023
Communication – The Unified Patent Court appoints 21 technically qualified judges Following the decision of the Administrative Committee dated 2 June 2023, 21 new technically qualified judges have been appointed to the UPC. Following a recent recruitment procedure, which took place during spring 2023, 21 new technically qualified judges have been appointed to the Court. […]
READ MOREPosted: July 27th, 2023
Communication – oath taking of 21 technically qualified judges of the Unified Patent Court “Following the decision of the Administrative Committee dated 2 June 2023, 21 new technically qualified judges have been appointed at the UPC. Before taking up their duties, they shall take an oath in open court. “For this purpose, open court sessions […]
READ MOREPosted: June 29th, 2023
Communication on the 7th UPC Administrative Committee meeting on 26 June 2023 “Contracting Member States of the Unified Patent Court have met in a meeting of the Administrative Committee on 26 June. The meeting was held in video-conference format. “Contracting Member States of the Unified Patent Court have met in a meeting of the Administrative […]
READ MORE